StonvexLoading…
StonvexStonvexStonvexCore line items from TDOC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.53B | $2.57B | $2.60B | $2.41B |
Operating Income | $-262.95M | $-1.02B | $-248.55M | $-13.65B |
Net Income | $-200.32M | $-1.00B | $-220.37M | $-13.66B |
EPS (Diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 |
Total Assets | $2.86B | $3.52B | $4.39B | $4.35B |
Total Liabilities | $1.47B | $2.03B | $2.07B | Not available |
Cash & Equivalents | $781.08M | $1.30B | $1.12B | $918.18M |
Free Cash Flow OCF − CapEx | $285.46M | $282.89M | $338.56M | $172.81M |
Shares Outstanding | 178.32M | 173.41M | 166.66M | 162.84M |